WebMay 10, 2024 · Telara Pharma has signed an exclusive worldwide license agreement with the Canadian company Arch Biopartners to use cilastatin in the treatment and prevention of acute kidney injury and in sepsis processes. Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the … WebMay 11, 2024 · Telara Pharma - Funding, Financials, Valuation & Investors Organization Telara Pharma Summary Financials People Technology Signals & News Similar Companies Highlights Funding Rounds 1 Total Funding Amount €100K Lead Investors 1 Investors 1 Funding Telara Pharma has raised a total of €100K in funding over 1 round.
Telara Pharma – Developing therapeutic solutions for the …
WebApr 15, 2024 · The patents held by Arch and Telara are now unified into one clinical development program to be led by Arch. These patents include method of use claims for the use of cilastatin as a potential... WebApr 15, 2024 · Arch Biopartners ( OTCQB:ACHFF) announces that it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain to clinically develop and market cilastatin, a... fake it germania
Arch Biopartners Enters into Worldwide License Agreement with …
WebApr 15, 2024 · Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin for the Treatment and Prevention of Acute Kidney Injury [April 15, 2024] Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammation WebApr 15, 2024 · Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammationNovel Mechanism of Action - selective dipeptidase-1 antagonists that... March 8, 2024 WebApr 16, 2024 · Arch Biopartners Inc. has announced the signing of a licensing agreement with Telara Pharma SL for its patents relating to Cilastatin, dipeptidase-1 (DPEP-1) antagonists. The licensing deal which awards commercial rights for the patents, is put through mainly for Arch to use them in developing a treatment for acute kidney injury. dollywood dreammore resort facebook